Richter Rises to Record as KBC Sees Cariprazine Drug Priced In

Updated on

Shares in Richter Gedeon Nyrt.’s, central Europe’s largest maker of contraceptives, rose to the highest close on record as investors priced in the full expected effect of selling its Cariprazine drug in the U.S. market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.